Evidence map›Paper›PMID 15163725›Full record

ArticleJournal of virology2004

Proteolytic cleavage of the catalytic subunit of DNA-dependent protein kinase during poliovirus infection.

Kareem L Graham, Kurt E Gustin, Carlos Rivera, N Muge Kuyumcu-Martinez, Sunny S Choe, Richard E Lloyd, Peter Sarnow, Paul J Utz

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Viral security proteins: counteracting host defences.Nature reviews. Microbiology · 2010
    Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Kareem L GrahamDivision of Immunology and Rheumatology, Stanford University School of Medicine, Stanford University School of Medicine, CCSR Building, Room 2215A, 269 Campus Drive, Stanford, CA 94305, USA.
Kurt E Gustin
Carlos Rivera
N Muge Kuyumcu-Martinez
Sunny S Choe
Richard E Lloyd
Peter Sarnow
Paul J Utz
Baylor College of Medicine · USStanford University · USCenter for Rheumatology · US

Funding

Virginia Mason/UCHSC Autoimmune Prevention CenterU19AI050864 · NIAID · UNIVERSITY OF COLORADO DENVER · PI HOLERS, VERNON MICHAEL · 2001 to 2011
$29.2M
MOLECULAR &CELLULAR IMMUNOBIOLOGYT32AI007290 · NIAID · STANFORD UNIVERSITY · PI Sean Curtis Bendall, Olivia M Martinez · 1985 to 2026
$27.0M
Translation Regulation by Enterovirus ProteinaseR01AI050237 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI LLOYD, RICHARD E · 2002 to 2022
$6.9M
Strategies for Prevention of AutoimmunityU19DK061934 · NIDDK · STANFORD UNIVERSITY · PI FATHMAN, CHARLES GARRISON · 2001 to 2005
$4.4M
MECHANISMS OF TRANSLATION CONTROL DURING APOPTOSISR01GM059803 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI LLOYD, RICHARD E · 1999 to 2007
$2.2M
Multiplex Autoantibody Profiling in SLER01AI051614 · NIAID · STANFORD UNIVERSITY · PI UTZ, PAUL JOSEPH · 2003 to 2007
$1.9M
STRUCTURE/FUNCTION OF THE POLIOVIRUS RNA GENOMER01AI025105 · NIAID · UNIVERSITY OF COLORADO DENVER · PI SARNOW, PETER · 1992 to 2002
$742k
Translation Regulation by Enterovirus ProteinaseR56AI050237 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI LLOYD, RICHARD E · 2007 to 2007
$384k
Autoantigen Arrays to Select Vaccines for Model of PBCR21AR049328 · NIAMS · STANFORD UNIVERSITY · PI UTZ, PAUL JOSEPH · 2002 to 2003
$159k
THE ROLE OF GRANZYME B IN THE DEVELOPMENT OF MURINE SLEF31AI010663 · NIAID · STANFORD UNIVERSITY · PI GRAHAM, KAREEM L · 2001 to 2003
$130k
STRUCTURE AND FUNCTION OF THE POLIOVIRUS RNA GENOMER29AI025105 · NIAID · UNIVERSITY OF COLORADO DENVER · PI SARNOW, PETER · 1987 to 1991
–
STRUCTURE/FUNCTION OF PICORNAVIRUS RNA GENOMESR21AI025105 · NIAID · STANFORD UNIVERSITY · PI SARNOW, PETER · 1997 to 1997
–
NIAID NIH HHS AI 10663-02NIAID NIH HHS AI 25105NIAID NIH HHS AI 49328-02NIAID NIH HHS AI 50237NIAID NIH HHS AI 50864NIAID NIH HHS AI 50865-03NIAID NIH HHS AI 51614-01NIAID NIH HHS F31 AI010663NIAID NIH HHS R01 AI050237NIAID NIH HHS R01 AI051614NIAID NIH HHS R56 AI050237NIAID NIH HHS T32 AI007290NIAID NIH HHS U19 AI050864NIAMS NIH HHS R21 AR049328NIDDK NIH HHS DK 61934NIDDK NIH HHS U19 DK061934NIGMS NIH HHS GM 59803NIGMS NIH HHS R01 GM059803
6 · The paper itself

Abstract

DNA-dependent protein kinase (DNA-PK) is a serine/threonine kinase that has critical roles in DNA double-strand break repair, as well as B- and T-cell antigen receptor rearrangement. The DNA-PK enzyme consists of the Ku regulatory subunit and a 450-kDa catalytic subunit termed DNA-PK(CS). Both of these subunits are autoantigens associated with connective tissue diseases such as systemic lupus erythematosus (SLE) and scleroderma. In this report, we show that DNA-PK(CS) is cleaved during poliovirus infection of HeLa cells. Cleavage was visible as early as 1.5 h postinfection (hpi) and resulted in an approximately 40% reduction in the levels of native protein by 5.5 hpi. Consistent with this observation, the activity of the DNA-PK(CS) enzyme was also reduced during viral infection, as determined by immunoprecipitation kinase assays. Although it has previously been shown that DNA-PK(CS) is a substrate of caspase-3 in vitro, the protein was still cleaved during poliovirus infection of the caspase-3-deficient MCF-7 cell line. Cleavage was not prevented by infection in the presence of a soluble caspase inhibitor, suggesting that cleavage in vivo was independent of host caspase activation. DNA-PK(CS) is directly cleaved by a picornaviral 2A protease in vitro, producing a fragment similar in size to the cleavage product observed in vivo. Taken together, our results indicate that DNA-PK(CS) is cleaved by the 2A protease during poliovirus infection. Proteolytic cleavage of DNA-PK(CS) during poliovirus infection may contribute to inhibition of host immune responses. Furthermore, cleavage of autoantigens by viral proteases may target these proteins for the autoimmune response by generating novel, or "immunocryptic," protein fragments.

Indexed as

DNA-Binding ProteinsViral ProteinsCaspase 3Caspase InhibitorsCaspasesCatalytic DomainCell LineCysteine EndopeptidasesDNA-Activated Protein KinaseEnzyme InhibitorsHeLa CellsHumansNuclear ProteinsPoliovirusProtein Serine-Threonine KinasesCASP3 protein, humanCaspase 3Caspase InhibitorsCaspasesCysteine EndopeptidasesDNA-Activated Protein KinaseDNA-Binding ProteinsEnzyme InhibitorsNuclear Proteinspicornain 2A, PicornavirusPRKDC protein, humanProtein Serine-Threonine KinasesViral Proteins

Identifiers

PMID15163725
PMCPMC416498
OpenAlexW2135602222

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.